Evidence map›Paper›PMID 40910307›Full record

ArticleSe pu = Chinese journal of chromatography2025

[Determination of 26 perfluorinated and polyfluoroalkyl compounds in human serum by solid-phase extraction-high performance liquid chromatography-tandem mass spectrometry].

Ying-Xiao Yue, Ya-Ting Bian, Yu-Fan Cheng, Lu He, Dan Wang, Pei-Xia Yan, Wei Yan, Gui-Ying Liu, Huan Song, Liang-Po Liu

Abstract readEnglish Abstract
In one paragraph

Article in Se pu = Chinese journal of chromatography, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ying-Xiao YueDepartment of Public Health Laboratory Sciences,School of Public Health,Shanxi Medical University,Taiyuan 030001,China.
Ya-Ting BianDepartment of Public Health Laboratory Sciences,School of Public Health,Shanxi Medical University,Taiyuan 030001,China.
Yu-Fan ChengDepartment of Public Health Laboratory Sciences,School of Public Health,Shanxi Medical University,Taiyuan 030001,China.
Lu HeDepartment of Public Health Laboratory Sciences,School of Public Health,Shanxi Medical University,Taiyuan 030001,China.
Dan WangDepartment of Public Health Laboratory Sciences,School of Public Health,Shanxi Medical University,Taiyuan 030001,China.
Pei-Xia YanBeijing Changping District Center for Disease Prevention and Control,Beijing 102200,China.
Wei YanDepartment of Public Health Laboratory Sciences,School of Public Health,Shanxi Medical University,Taiyuan 030001,China.
Gui-Ying LiuDepartment of Public Health Laboratory Sciences,School of Public Health,Shanxi Medical University,Taiyuan 030001,China.
Huan SongDepartment of Public Health Laboratory Sciences,School of Public Health,Shanxi Medical University,Taiyuan 030001,China.
Liang-Po LiuDepartment of Public Health Laboratory Sciences,School of Public Health,Shanxi Medical University,Taiyuan 030001,China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Perfluorinated and polyfluoroalkyl compounds (PFASs) represent a category of synthetic chemicals renowned for their environmental persistence. Owing to their hydrophobic, oleophobic, and high-temperature-resistant properties, PFASs are extensively utilized in industrial, agricultural, and civilian sectors, including applications in leather, textiles, flame-retardant materials, lubricants, and coatings, among others. PFASs can accumulate within the human body, exhibiting multi-organ toxicity. Continuous monitoring of PFASs with ambiguous toxicity profiles is vital for evaluating human exposure and associated health risks. Consequently, the establishment of a high-throughput and highly sensitive detection method is of paramount importance for accurately assessing the exposure levels of PFASs in the human body. In this study, a commercial high-throughput HMR-Lipid 96-well solid-phase extraction plate was adopted, combined with high performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS), to establish a simple, efficient method that can simultaneously quantitatively detect 26 PFASs in human serum. Serum samples were extracted using the HMR-lipid 96-well solid-phase extraction plate. The Phenomenex C

Indexed as

FluorocarbonsSolid Phase ExtractionTandem Mass SpectrometryChromatography, High Pressure LiquidEnvironmental PollutantsHumansEnvironmental PollutantsFluorocarbonshigh performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS)HMR-lipid 96-well solid-phase extraction platehuman serumperfluorinated and polyfluoroalkyl compounds (PFASs)

Identifiers

PMID40910307
PMCPMC12412018

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.